Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc

Journal of Proteome Research

Volumn 10, Issue 12, 2011, Pages 5326-5337

  Pocsfalvi, Gabriella ^a   Votta, Giuseppina ^b   De Vincenzo, Anna ^b   Fiume, Immacolata ^a   Raj, Delfin Albert Amal ^a   Marra, Giancarlo ^c   Stoppelli, Maria Patrizia ^b   Iaccarino, Ingram ^b  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

c ICAT; c Myc; colorectal cancer; ECM; oncogenic transformation; secretome; senescence

Indexed keywords

MYC PROTEIN; SECRETORY PROTEIN;

ARTICLE; AUTOCRINE EFFECT; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEOPLASM; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS;

ANIMALS; AUTOCRINE COMMUNICATION; CELL AGING; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; MICE; PARACRINE COMMUNICATION; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MYC; SWISS 3T3 CELLS; TRANSCRIPTIONAL ACTIVATION;

EID: 82755182017     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200584y     Document Type: Article

References (60)

1. Pietras, K.; Östman, A. Hallmarks of cancer: Interactions with the tumor stroma Exp. Cell Res. 2010, 316, 1324-1331
2. Bhowmick, N. A.; Moses, H. L. Tumor-stroma interactions Curr. Opin. Genet. Dev. 2005, 15, 97-101 (Pubitemid 40127637)
3. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100, 57-70 (Pubitemid 30046295)
4. Schulze, A.; Lehmann, K.; Jefferies, H. B.; McMahon, M.; Downward, J. Analysis of the transcriptional program induced by Raf in epithelial cells Genes Dev. 2001, 15, 981-994 (Pubitemid 32323548)
5. Wajapeyee, N.; Serra, R. W.; Zhu, X.; Mahalingam, M.; Green, M. R. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7 Cell 2008, 132, 363-374 (Pubitemid 351191995)
6. van Riggelen, J.; Müller, J.; Otto, T.; Beuger, V.; Yetil, A.; Choi, P. S.; Kosan, C.; Möröy, T.; Felsher, D. W.; Eilers, M. The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance Genes Dev. 2010, 24, 1281-1294
7. Adams, P. D.; Enders, G. H. Wnt-signaling and senescence: A tug of war in early neoplasia? Cancer Biol. Ther. 2008, 7, 1706-1711
8. Kuilman, T.; Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress Nat. Rev. Cancer 2009, 9, 81-94
9. Nesbit, C. E.; Tersak, J. M.; Prochownik, E. V. MYC oncogenes and human neoplastic disease Oncogene 1999, 18, 3004-3016 (Pubitemid 29276540)
10. Eilers, M.; Eisenman, R. N. Myc's broad reach Genes Dev. 2008, 22, 2755-2766
11. Alfano, D.; Votta, G.; Schulze, A.; Downward, J.; Caputi, M.; Stoppelli, M. P.; Iaccarino, I. Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor Mol. Cell. Biol. 2010, 30, 1838-1851
12. Zhuang, D.; Mannava, S.; Grachtchouk, V.; Tang, W.-H.; Patil, S.; Wawrzyniak, J. A.; Berman, A. E.; Giordano, T. J.; Prochownik, E. V.; Soengas, M. S.; Nikiforov, M. A. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells Oncogene 2008, 27, 6623-6634
13. Soucek, L.; Whitfield, J.; Martins, C. P.; Finch, A. J.; Murphy, D. J.; Sodir, N. M.; Karnezis, A. N.; Swigart, L. B.; Nasi, S.; Evan, G. I. Modelling Myc inhibition as a cancer therapy Nature 2008, 455, 679-683
14. Fernandez, P. C.; Frank, S. R.; Wang, L.; Schroeder, M.; Liu, S.; Greene, J.; Cocito, A.; Amati, B. Genomic targets of the human c-Myc protein Genes Dev. 2003, 17, 1115-1129 (Pubitemid 36534986)
15. Shiio, Y.; Donohoe, S.; Yi, E. C.; Goodlett, D. R.; Aebersold, R.; Eisenman, R. N. Quantitative proteomic analysis of Myc oncoprotein function EMBO J. 2002, 21, 5088-5096
16. Shiio, Y.; Eisenman, R. N.; Yi, E. C.; Donohoe, S.; Goodlett, D. R.; Aebersold, R. Quantitative proteomic analysis of chromatin-associated factors J. Am. Soc. Mass Spectrom. 2003, 14, 696-703 (Pubitemid 36870952)
17. Shiio, Y.; Suh, K. S.; Lee, H.; Yuspa, S. H.; Eisenman, R. N.; Aebersold, R. Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4 J. Biol. Chem. 2006, 281, 2750-2756 (Pubitemid 43845738)
18. Dews, M.; Homayouni, A.; Yu, D.; Murphy, D.; Sevignani, C.; Wentzel, E.; Furth, E.; Lee, W.; Enders, G.; Mendell, J.; Thomas-Tikhonenko, A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat. Genet. 2006, 38, 1060-1065 (Pubitemid 44325933)
19. Sodir, N. M.; Swigart, L. B.; Karnezis, A. N.; Hanahan, D.; Evan, G. I.; Soucek, L. Endogenous Myc maintains the tumor microenvironment Genes Dev. 2011, 25, 907-916
20. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75, 4646-4658 (Pubitemid 37082259)
21. Käll, L.; Storey, J. D.; MacCoss, M. J.; Noble, W. S. Assigning significance to peptides identified by tandem mass spectrometry using decoy databases J. Proteome Re.s 2008, 7, 29-34 (Pubitemid 351171110)
22. Mortensen, P.; Gouw, J. W.; Olsen, J. V.; Ong, S.-E.; Rigbolt, K. T. G.; Bunkenborg, J.; Cox, J.; Foster, L. J.; Heck, A. J. R.; Blagoev, B.; Andersen, J. S.; Mann, M. MSQuant, an open source platform for mass spectrometry-based quantitative proteomics J. Proteome Res. 2010, 9, 393-403
23. Emanuelsson, O.; Brunak, S.; von Heijne, G.; Nielsen, H. Locating proteins in the cell using TargetP, SignalP and related tools Nat. Protoc. 2007, 2, 953-971 (Pubitemid 46745592)
24. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 2004, 17, 349-356 (Pubitemid 39093515)
25. Yu, L.; Guo, Y.; Zhang, Z.; Li, Y.; Li, M.; Li, G.; Xiong, W.; Zeng, Y. SecretP: a new method for predicting mammalian secreted proteins Peptides 2010, 31, 574-578
26. Sabates-Bellver, J.; Van der Flier, L. G.; de Palo, M.; Cattaneo, E.; Maake, C.; Rehrauer, H.; Laczko, E.; Kurowski, M. A.; Bujnicki, J. M.; Menigatti, M.; Luz, J.; Ranalli, T. V.; Gomes, V.; Pastorelli, A.; Faggiani, R.; Anti, M.; Jiricny, J.; Clevers, H.; Marra, G. Transcriptome profile of human colorectal adenomas Mol. Cancer Res. 2007, 5, 1263-1275
27. Khwaja, F. W.; Svoboda, P.; Reed, M.; Pohl, J.; Pyrzynska, B.; Van Meir, E. G. Proteomic identification of the wt-p53-regulated tumor cell secretome Oncogene 2006, 25, 7650-7661 (Pubitemid 44924478)
28. Zhou, H.; Xiao, Y.; Li, R.; Hong, S.; Li, S.; Wang, L.; Zeng, R.; Liao, K. Quantitative analysis of secretome from adipocytes regulated by insulin Acta Biochim. Biophys. Sin. 2009, 41, 910-921
29. Li, J.; Steen, H.; Gygi, S. P. Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents: the yeast salinity stress response Mol. Cell. Proteomics 2003, 2, 1198-1204
30. Yi, E. C.; Li, X.-J.; Cooke, K.; Lee, H.; Raught, B.; Page, A.; Aneliunas, V.; Hieter, P.; Goodlett, D. R.; Aebersold, R. Increased quantitative proteome coverage with (13)C/(12)C-based, acid-cleavable isotope-coded affinity tag reagent and modified data acquisition scheme Proteomics 2005, 5, 380-387 (Pubitemid 40262054)
31. Vaughn, C. P.; Crockett, D. K.; Lim, M. S.; Elenitoba-Johnson, K. S. J. Analytical characteristics of cleavable isotope-coded affinity tag-LC-tandem mass spectrometry for quantitative proteomic studies J. Mol. Diagn. 2006, 8, 513-520 (Pubitemid 44377935)
32. Mor-Vaknin, N.; Punturieri, A.; Sitwala, K.; Markovitz, D. M. Vimentin is secreted by activated macrophages Nat. Cell Biol. 2003, 5, 59-63 (Pubitemid 36054330)
33. Gnanasekar, M.; Thirugnanam, S.; Zheng, G.; Chen, A.; Ramaswamy, K. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells Int. J. Oncol. 2009, 34, 1241-1246
34. Amzallag, N.; Passer, B. J.; Allanic, D.; Segura, E.; Théry, C.; Goud, B.; Amson, R.; Telerman, A. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway J. Biol. Chem. 2004, 279, 46104-46112 (Pubitemid 39491604)
35. Evan, G. I.; d' Adda di Fagagna, F. Cellular senescence: hot or what? Curr. Opin. Genet. Dev 2009, 19, 25-31
36. Reuter, J. A.; Ortiz-Urda, S.; Kretz, M.; Garcia, J.; Scholl, F. A.; Pasmooij, A. M. G.; Cassarino, D.; Chang, H. Y.; Khavari, P. A. Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression Cancer Cell 2009, 15, 477-488
37. Collado, M.; Blasco, M. A.; Serrano, M. Cellular senescence in cancer and aging Cell 2007, 130, 223-233 (Pubitemid 47081143)
38. Dhomen, N.; Reis-Filho, J. S.; da Rocha Dias, S.; Hayward, R.; Savage, K.; Delmas, V.; Larue, L.; Pritchard, C.; Marais, R. Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice Cancer Cell 2009, 15, 294-303
39. Wu, C.-H.; van Riggelen, J.; Yetil, A.; Fan, A. C.; Bachireddy, P.; Felsher, D. W. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 13028-13033 (Pubitemid 351737587)
40. Kuilman, T.; Michaloglou, C.; Mooi, W. J.; Peeper, D. S. The essence of senescence Genes Dev. 2010, 24, 2463-2479
41. Edmondson, S. R.; Russo, V. C.; McFarlane, A. C.; Wraight, C. J.; Werther, G. A. Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth J. Clin. Endocrinol. Metab. 1999, 84, 1638-1644 (Pubitemid 30644268)
42. Babajko, S.; Leneuve, P.; Loret, C.; Binoux, M. IGF-binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells: its production is both IGF- and cell density-dependent J. Endocrinol. 1997, 152, 221-227 (Pubitemid 27115771)
43. Ruan, W.; Xu, E.; Xu, F.; Ma, Y.; Deng, H.; Huang, Q.; Lv, B.; Hu, H.; Lin, J.; Cui, J.; Di, M.; Dong, J.; Lai, M. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis Cancer Biol. Ther. 2007, 6, 354-359 (Pubitemid 47328302)
44. Jee, C. D.; Kim, M. A.; Jung, E. J.; Kim, J.; Kim, W. H. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma Eur. J. Cancer 2009, 45, 1282-1293
45. Gunawardana, C. G.; Kuk, C.; Smith, C. R.; Batruch, I.; Soosaipillai, A.; Diamandis, E. P. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer J. Proteome Res. 2009, 8, 4705-4713
46. Ye, X.; Zerlanko, B.; Kennedy, A.; Banumathy, G.; Zhang, R.; Adams, P. D. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells Mol. Cell 2007, 27, 183-196 (Pubitemid 47058300)
47. Cowling, V. H.; D'Cruz, C. M.; Chodosh, L. A.; Cole, M. D. c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1 Mol. Cell. Biol. 2007, 27, 5135-5146 (Pubitemid 47068288)
48. Lodygin, D.; Epanchintsev, A.; Menssen, A.; Diebold, J.; Hermeking, H. Functional epigenomics identifies genes frequently silenced in prostate cancer Cancer Res. 2005, 65, 4218-4227 (Pubitemid 40775660)
49. Kuphal, S.; Lodermeyer, S.; Bataille, F.; Schuierer, M.; Hoang, B. H.; Bosserhoff, A. K. Expression of Dickkopf genes is strongly reduced in malignant melanoma Oncogene 2006, 25, 5027-5036
50. Sumitomo, K.; Kurisaki, A.; Yamakawa, N.; Tsuchida, K.; Shimizu, E.; Sone, S.; Sugino, H. Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines Cancer Lett. 2000, 155, 37-46 (Pubitemid 30256222)
51. Chan, Q. K. Y.; Ngan, H. Y. S.; Ip, P. P. C.; Liu, V. W. S.; Xue, W. C.; Cheung, A. N. Y. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis Carcinogenesis 2009, 30, 114-121
52. Mohamed, M. M.; Sloane, B. F. Cysteine cathepsins: multifunctional enzymes in cancer Nat. Rev. Cancer 2006, 6, 764-775 (Pubitemid 44450465)
53. Byun, H.-O.; Han, N.-K.; Lee, H.-J.; Kim, K.-B.; Ko, Y.-G.; Yoon, G.; Lee, Y.-S.; Hong, S.-I.; Lee, J.-S. Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence Cancer Res. 2009, 69, 4638-4647
54. Besancenot, R.; Chaligné, R.; Tonetti, C.; Pasquier, F.; Marty, C.; Lécluse, Y.; Vainchenker, W.; Constantinescu, S. N.; Giraudier, S. A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation PLoS Biol. 2010, 8
55. Coppé, J.-P.; Patil, C. K.; Rodier, F.; Sun, Y.; Muñoz, D. P.; Goldstein, J.; Nelson, P. S.; Desprez, P.-Y.; Campisi, J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor PLoS Biol. 2008, 6, 2853-2868
56. Bao, X.; Kobayashi, M.; Hatakeyama, S.; Angata, K.; Gullberg, D.; Nakayama, J.; Fukuda, M. N.; Fukuda, M. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N- acetylglucosaminyltransferase Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 12109-12114
57. Frye, M.; Gardner, C.; Li, E. R.; Arnold, I.; Watt, F. M. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment Development 2003, 130, 2793-2808 (Pubitemid 37069593)
58. Frisch, S. M.; Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis J. Cell Biol. 1994, 124, 619-626 (Pubitemid 24064472)
59. Moreno, M.; Muñoz, R.; Aroca, F.; Labarca, M.; Brandan, E.; Larraín, J. Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway EMBO J. 2005, 24, 1397-1405 (Pubitemid 40593060)
60. Barton, C. A.; Gloss, B. S.; Qu, W.; Statham, A. L.; Hacker, N. F.; Sutherland, R. L.; Clark, S. J.; O'Brien, P. M. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival Br. J. Cancer 2010, 102, 87-96